Related Experiment Video

Updated: Jul 18, 2026

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence
10:52

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence

Published on: December 23, 2022

Stroke in congenital heart disease and patent foramen ovale

Rafael Hirsch1, Jonathan Y Streifler

  • 1Adult Congenital Heart Unit, Department of Cardiology, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel. rafaelh@clalit.org.il

The Israel Medical Association Journal : IMAJ
|December 22, 2006
PubMed

Insights

Patent foramen ovale (PFO), a common heart defect, is increasingly linked to stroke. Understanding PFO within congenital heart disease context is key to assessing stroke risk and individual patient management.

Area of Science:

  • Cardiology
  • Neurology
  • Vascular Medicine

Background:

  • Congenital heart disease (CHD) is often specialized, but patent foramen ovale (PFO) association with stroke has gained public and medical attention.
  • The link between PFO and stroke has become a significant medical debate, particularly in Israel.
  • Viewing PFO as part of the broader spectrum of CHD offers a clearer understanding of its role in stroke.

Purpose of the Study:

  • To contextualize patent foramen ovale (PFO) within congenital heart disease (CHD) for better stroke risk assessment.
  • To critically evaluate the role of PFO in stroke patients by considering blood flow dynamics and paradoxical embolism.
  • To discuss factors influencing clot formation and review treatment options for PFO-related stroke.

Main Methods:

  • Review of existing literature on congenital heart disease, patent foramen ovale, and stroke.
  • Analysis of paradoxical embolism as a stroke mechanism unique to CHD.
  • Individual case evaluation principles based on blood flow and embolic risk factors.

Main Results:

  • Paradoxical embolism, a unique stroke mechanism in CHD, is influenced by shunt direction and volume.
  • Individual assessment of PFO in stroke patients is crucial, considering specific risk factors.
  • Factors promoting embolic material formation and various treatment strategies are presented.

Conclusions:

  • Understanding PFO within the broader CHD framework is essential for stroke risk evaluation.
  • Individualized patient assessment, considering shunting dynamics and embolic risk, is paramount.
  • Effective management involves addressing clot formation factors and exploring diverse treatment modalities.

More Related Videos

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

Permanent Cerebral Vessel Occlusion via Double Ligature and Transection08:22

Permanent Cerebral Vessel Occlusion via Double Ligature and Transection

Published on: July 21, 2013

Related Concept Videos

Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
The Arch of Aorta01:10

The Arch of Aorta

The coronary arteries, originating from the ascending aorta, bifurcate from two sinuses located within the ascending aorta. Positioned just above the aortic semilunar valve, these sinuses house essential aortic baroreceptors and chemoreceptors, crucial for maintaining cardiac function. The left coronary artery and the right coronary artery branch off from the left posterior and anterior aortic sinuses, respectively.
Encircling the heart, the coronary arteries form a ring-like structure before...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...